Aethlon Medical (AEMD) Stock Price, Quote & News

Company Profile

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Industry: Medical Devices

Sector: Healthcare

Phone: 619 941 0360

Fax: 619 941 0361

Website: www.aethlonmedical.com

Address:

11555 Sorrento Valley Road, Suite 203, San Diego, United States

FullPortCreed Dec. 5 at 2:49 AM

Insane call dude, Made a nice 6k$ on your alert! If you like jumping in to them runners early, I would recommend you FOLLOW @ReversalFox guy below. One of the best traders i know right now. 💯 Swings on $KITT $AEMD $BGLC $VRAX Z

0 · Reply

Krazek24 Dec. 4 at 4:47 PM

$AEMD someone turn up the volume please

1 · Reply

Adrob75 Dec. 4 at 4:28 PM

$AEMD Might pop of it breaks $4

1 · Reply

Recon2023 Dec. 4 at 3:37 PM

$AEMD 5,75

0 · Reply

Bazzzigar Dec. 4 at 12:24 PM

$AEMD join with PURR

0 · Reply

Stockrunners1 Dec. 3 at 9:29 PM

$AEMD shines tomorrow.$TOVX great longterm hold! Do DD as always!

0 · Reply

UgoGreg Dec. 3 at 5:48 PM

$AEMD https://youtu.be/EGIGtyQGZaA

0 · Reply

Golibajje Dec. 3 at 3:31 PM

$AEMD Any company deals with scamster Armistice Capital.. you will only lose money there!! offering at the lowest.. results are not peer reviewed!! Well… they work only for Armistice!

0 · Reply

AlwaysLearning72 Dec. 3 at 3:22 PM

$AEMD can we see a bounce when shorts cover?

0 · Reply

PostQCLSpaidlendinginfo Dec. 3 at 2:58 PM

$QCLS $AEMD that is some junk biotech; this is real quantum tech

1 · Reply

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs

Nov 12, 2025, 6:31 PM EST - 22 days ago

Aethlon Medical, Inc. (AEMD) Q2 2026 Earnings Call Transcript

Nov 12, 2025, 4:15 PM EST - 22 days ago

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

Nov 7, 2025, 8:01 AM EST - 27 days ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

Oct 7, 2025, 8:01 AM EDT - 2 months ago

Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial

Sep 4, 2025, 9:15 AM EDT - 3 months ago

Aethlon Medical Announces Pricing of $4.5 Million Public Offering

Sep 3, 2025, 8:01 AM EDT - 3 months ago

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

Aug 13, 2025, 8:01 PM EDT - 4 months ago

Aethlon Medical, Inc. (AEMD) Q1 2026 Earnings Call Transcript

Aug 13, 2025, 4:15 PM EDT - 4 months ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

Aug 5, 2025, 8:01 AM EDT - 4 months ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025

Jul 15, 2025, 8:01 AM EDT - 5 months ago

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

Jun 26, 2025, 7:35 PM EDT - 5 months ago

Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript

Jun 26, 2025, 4:15 PM EDT - 5 months ago

Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Jun 20, 2025, 8:01 AM EDT - 5 months ago

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

Jun 18, 2025, 8:01 AM EDT - 6 months ago

Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

Jun 9, 2025, 8:01 AM EDT - 6 months ago

Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

May 14, 2025, 8:01 AM EDT - 7 months ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

Mar 10, 2025, 8:01 AM EDT - 9 months ago

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Feb 13, 2025, 8:01 AM EST - 10 months ago

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Feb 12, 2025, 8:11 PM EST - 10 months ago

Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript

Feb 12, 2025, 4:15 PM EST - 10 months ago

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Feb 5, 2025, 8:01 AM EST - 10 months ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Jan 29, 2025, 8:01 AM EST - 11 months ago

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Dec 20, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Nov 14, 2024, 8:00 AM EST - 1 year ago

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Nov 13, 2024, 7:58 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript

Nov 13, 2024, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Nov 12, 2024, 8:00 AM EST - 1 year ago

Innovative Medical Technology Advances with First Patient Enrollments

Nov 11, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Nov 6, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Oct 8, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Sep 19, 2024, 8:01 AM EDT - 1 year ago

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Sep 17, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Present at Virtual Investor Conferences in September

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Innovation Driving Cancer's Solid Tumors Market

Sep 16, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Sep 13, 2024, 8:35 AM EDT - 1 year ago

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Aug 27, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aug 14, 2024, 6:45 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call Transcript

Aug 14, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

Aug 12, 2024, 9:01 AM EDT - 1 year ago

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aug 12, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aug 6, 2024, 9:12 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Jun 27, 2024, 6:37 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript

Jun 27, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Jun 21, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Jun 20, 2024, 7:00 AM EDT - 1 year ago

What's Next in Treatments for Cancer Patients with Solid Tumors?

Jun 18, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

Jun 7, 2024, 8:00 AM EDT - 1 year ago

The Hunt for Virus Treatments Continues Post Covid-19

Jun 3, 2024, 9:05 AM EDT - 1 year ago

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

FullPortCreed Dec. 5 at 2:49 AM

0 · Reply

Krazek24 Dec. 4 at 4:47 PM

$AEMD someone turn up the volume please

1 · Reply

Adrob75 Dec. 4 at 4:28 PM

$AEMD Might pop of it breaks $4

1 · Reply

Recon2023 Dec. 4 at 3:37 PM

$AEMD 5,75

0 · Reply

Bazzzigar Dec. 4 at 12:24 PM

$AEMD join with PURR

0 · Reply

Stockrunners1 Dec. 3 at 9:29 PM

$AEMD shines tomorrow.$TOVX great longterm hold! Do DD as always!

0 · Reply

UgoGreg Dec. 3 at 5:48 PM

$AEMD https://youtu.be/EGIGtyQGZaA

0 · Reply

Golibajje Dec. 3 at 3:31 PM

$AEMD Any company deals with scamster Armistice Capital.. you will only lose money there!! offering at the lowest.. results are not peer reviewed!! Well… they work only for Armistice!

0 · Reply

AlwaysLearning72 Dec. 3 at 3:22 PM

$AEMD can we see a bounce when shorts cover?

0 · Reply

PostQCLSpaidlendinginfo Dec. 3 at 2:58 PM

$QCLS $AEMD that is some junk biotech; this is real quantum tech

1 · Reply

cw9c Dec. 3 at 2:57 PM

$QCLS all over now...there's no end in sight on how far down this could go...honestly could pull a $AEMD move where it ends up -15-20% on the day...not a single real bounce since open

0 · Reply

Usethestockforce Dec. 3 at 2:32 PM

$AEMD the force wants $20 plus

0 · Reply

Intradaytrade100 Dec. 3 at 2:04 PM

$AEMD find pump and dumpers and lock em up...

0 · Reply

dbr_island Dec. 3 at 1:28 PM

$AEMD watching 🚨EPOW🚨 just received a $30M contract AH That is HUGE for a tiny company This should be at least $2 🎯✅ I’m even willing to put some of my TSLA COIN profits into EPOW👇💰💰💰

0 · Reply

Pinecone_Tradingz_ Dec. 3 at 1:07 PM

Thanks a lot, Great start to my month, up 3k profit :) If you like catching them early, i suggest you FOLLOW @ICEMAN_ALERTS below.. He's great. 🚀 Also holding $INHD $NXXT $TMC $AEMD !

0 · Reply

ForeverTrades Dec. 3 at 12:51 PM

🔥 🔥 :fire: Click to learn more 🔥 🔥 :fire: Click to learn more :fire: :fire: :fire: Click to learn more $AEMD UPDATE 🔥 🔥 :fire: Click to learn more 🔥 🔥 :fire: Click to learn more :fire: :fire: :fire: Click to learn more Potential Flag breakout here if buyers hold this above VWAP

0 · Reply

Tradebub Dec. 3 at 12:46 PM

$AEMD How's it going? You got a good deal in after hours.

0 · Reply

Rampageusa Dec. 3 at 12:42 PM

$AEMD scam of the year wait for 2.9 entry and turn around if at all. $SMX 66 TODAY,75 NEXT AND 500$ Eventually (if not offering ) $CMCT 3.3 level entry wait ( patience) and ride back to 5.5+ both SMX and CMCT low floaters and volume can explode. GLTA

0 · Reply

James9921 Dec. 3 at 11:04 AM

$AEMD offering taken into account we have now reached the bottom

1 · Reply

diagio Dec. 3 at 10:03 AM

$AEMD Covid huh? Looks like this stock caught Covid. 😂

1 · Reply

HorsePicks Dec. 3 at 9:37 AM

$AEMD like $CMCT low float structure

0 · Reply

BearTamerTrading Dec. 3 at 1:58 AM

🌙 After-Hours Alerts — Bear Tamer Trading 🔥 $CMCT — Heavy AH volatility following earlier weakness. Sharp bounce attempts but still trading under pressure; traders watching for reversal setups. 🔥 $KXIN — Big after-hours surge (+21%) as liquidity pours in. Auto/EV microcap names often get evening momentum — this one caught strong AH buyers. 🔥 $AEMD — Early AH strength from its intraday run, but pulling back sharply (-20%) as profit-taking ramps up. Still one of the cleaner morning winners. 🔥 $PMAX — Massive AH continuation (+46%). Strong demand carried over from late-day volume — clear momentum favorite heading into tomorrow. 💰👏 Huge congrats to everyone who ate during after-hours today. Here’s the proof — all alerted live ⬇️ 🔗 https://www.youtube.com/live/88jyEWIj-_4?si=4Hf6XxK-wTSUeRVk 🚀 Rest up — we do it again tomorrow.

0 · Reply

Market Cap	3.68M
Revenue (ttm)	0.00
Net Income (ttm)	-13.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	183,500
Avg Vol	121,976
Day's Range	N/A - N/A
Shares Out	761,000.00
Stochastic %K	18%
Beta	1.64
Analysts	Hold
Price Target	$9.75